Publications
Showing 501 to 510 of 554 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers | Vedel I*, Sheets D, McAiney C*, Clare L*, Brodaty H, Mann J, Anderson N*, Liu-Ambrose T*, Rojas-Rozo L, Loftus L, Gauthier S*, Sivananthan S | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia | Rockwood K*, Andrews MK*, Aubertin-Leheudre M, Belleville S*, Bherer L*, Bowles SK, Kehler DS, Lim A*, Middleton L*, Philips N*, Wallace LK | 2020 | Alzheimer's & Dementia: Translational Research & Clinical Interventions |
| A quadratic function of activation in individuals at risk of Alzheimer’s disease | Corriveau-Lecavalier N, Duchesne S*, Gauthier S*, Hudon C8, Kergoat MJ*, Mellah S, Belleville S* for the Consortium for the Early Identification of Alzheimer's Disease-Quebec (CIMA-Q) | 2021 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Canadian Indigenous Cognitive Assessment (CICA): Inter-rater reliability and criterion validity in Anishinaabe communities on Manitoulin Island, Canada | Walker J*, O'Connell ME*, Pitawanakwat K*, Blind M, Warry W, Lemieux A, Patterson CJ*, Allaby C, Valvasori M, Zhao Y, Jacklin K | 2021 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Resting-state network dysfunction in Alzheimer’s disease: A systematic review and meta-analysis. | Auteurs: Badhwar A, Tam A, Dansereau C, Orban P, Hoffstaedter F, Bellec P | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | |
| Relationship between frailty and Alzheimer’s disease biomarkers: A scoping review. | Wallace, L.*, Theou, O., Rockwood, K.**, Andrew, M.K.** | 2018 | Alzheimer's & dementia : diagnosis, assessment & disease monitoring |
| Plasma neurofilament light associates with Alzheimer’s disease metabolic decline in amyloid-positive individuals. | Benedet, AL.*, Ashton, NJ., Pascoal, TA.*, Leuzy, A., Mathotaarachchi, S.*, Kang, MS., Therriault, J.*, Savard, M.*, Chamoun, M., Scholl, M., Zimmer, ER., Gauthier, S.**, Labbe, A.*, Zetterberg, H., Blennow, K., Neto, PR**. | 2019 | Alzheimer's & dementia : diagnosis, assessment & disease monitoring |
| CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment | Brisson M, Brodeur C, Létourneau-Guillon L, Masellis M*, Stoessl J*, Tamm A, Zukotynski K, Ismail Z*, Gauthier S*, Rosa-Neto P*, Soucy JP* | 2021 | Alzheimer's & Dementia |
| Progress in transnational scientific and ethics review: Commentary on the proposal for a single North American review board for research on dementia | Gauthier, S., Robillard, J., & de Champlain, J. | 2018 | Alzheimer's & Dementia |
| Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards | Knopman, D., Alford, E., Tate, K., Long, M., & Khachaturian, A. S. | 2017 | Alzheimer's & Dementia |
Showing 501 to 510 of 554 Publications